Treatment With Tocilizumab in a Patient With COVID-۱۹

In late December ۲۰۱۹, a global outbreak (pandemic) of the coronavirus was reported, which WHO named ۲۰۱۹-nCoV. The virus is now spreading rapidly and has affected many countries, including Iran. There is no definitive and effective treatment for this virus yet. This report aimed to define the effect of Tocilizumab in patient with COVID-۱۹. This case report is about a ۵۲-year-old man with COVID-۱۹ that has been treated with tocilizumab. The reported patient had an acceptable improvement in oxygen saturation but no significant change in lung CT scan.  After ۳ days treatment patient with Tocilizumab, extensive bilateral lungs involvement still exist but SPO۲ level iimprovement up to ۹۰%. According to the results, this drug had a positive impact on oxygen saturation. However, we cannot be certain whether this drug positively affected the patient’s coronavirus disease.

Keywords:

Coronavirus , Tocilizumab , Pandemic , COVID-۱۹